» Articles » PMID: 30932909

Newly Identified T Cell Subsets in Mechanistic Studies of Food Immunotherapy

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2019 Apr 2
PMID 30932909
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Allergen-specific immunotherapy has shown promise for the treatment of food allergy and is currently being evaluated in clinical trials. Although immunotherapy can induce desensitization, the mechanisms underlying this process are not completely understood. Recent advances in high-throughput technologies along with concomitant advances in data analytics have enabled monitoring of cells at the single-cell level and increased the research focus on upstream cellular factors involved in the efficacy of immunotherapy, particularly the role of T cells. As our appreciation of different T cell subsets and their plasticity increases, the initial simplistic view that restoring Th1/Th2 balance by decreasing Th2 or increasing Th1 responses can ameliorate food allergy is being enhanced by a more complex model involving other T cell subsets, particularly Tregs. In this Review, we focus on the current understanding of T cell functions in food allergy, tolerance, and immunotherapy.

Citing Articles

Amelioration Effect of ZW3 on Ovalbumin-Induced Allergic Symptoms in BALB/c Mice.

Xu H, Duan X, Wang Y, Geng W Foods. 2025; 14(1.

PMID: 39796306 PMC: 11720023. DOI: 10.3390/foods14010016.


Clinical and immunological outcomes after randomized trial of baked milk oral immunotherapy for milk allergy.

Dantzer J, Lewis S, Psoter K, Sutherland A, Frazier A, Richardson E JCI Insight. 2025; 10(1.

PMID: 39782691 PMC: 11721308. DOI: 10.1172/jci.insight.184301.


Allergen-Encapsulating Nanoparticles Reprogram Pathogenic Allergen-Specific Th2 Cells to Suppress Food Allergy.

Saunders M, Rad L, Williams L, Landers J, Urie R, Hocevar S Adv Healthc Mater. 2024; 14(5):e2400237.

PMID: 38691819 PMC: 11527797. DOI: 10.1002/adhm.202400237.


Immune signatures predicting the clinical outcome of peanut oral immunotherapy: where we stand.

Wanniang N, Boehm T, Codreanu-Morel F, Divaret-Chauveau A, Assugeni I, Hilger C Front Allergy. 2023; 4:1270344.

PMID: 37849958 PMC: 10577271. DOI: 10.3389/falgy.2023.1270344.


Identification of cow milk epitopes to characterize and quantify disease-specific T cells in allergic children.

Lewis S, Sutherland A, Soldevila F, Westernberg L, Aoki M, Frazier A J Allergy Clin Immunol. 2023; 152(5):1196-1209.

PMID: 37604312 PMC: 10846667. DOI: 10.1016/j.jaci.2023.07.020.


References
1.
Vander Leek T, Liu A, Stefanski K, Blacker B, Bock S . The natural history of peanut allergy in young children and its association with serum peanut-specific IgE. J Pediatr. 2000; 137(6):749-55. DOI: 10.1067/mpd.2000.109376. View

2.
Abarbanel D, Seki S, Davies Y, Marlen N, Benavides J, Cox K . Immunomodulatory effect of vancomycin on Treg in pediatric inflammatory bowel disease and primary sclerosing cholangitis. J Clin Immunol. 2012; 33(2):397-406. PMC: 3565076. DOI: 10.1007/s10875-012-9801-1. View

3.
Branum A, Lukacs S . Food allergy among children in the United States. Pediatrics. 2009; 124(6):1549-55. DOI: 10.1542/peds.2009-1210. View

4.
Cukrowska B . Microbial and Nutritional Programming-The Importance of the Microbiome and Early Exposure to Potential Food Allergens in the Development of Allergies. Nutrients. 2018; 10(10). PMC: 6212882. DOI: 10.3390/nu10101541. View

5.
Chiang D, Chen X, Jones S, Wood R, Sicherer S, Burks A . Single-cell profiling of peanut-responsive T cells in patients with peanut allergy reveals heterogeneous effector T2 subsets. J Allergy Clin Immunol. 2018; 141(6):2107-2120. PMC: 5994177. DOI: 10.1016/j.jaci.2017.11.060. View